Current chemotherapy of schistosomiasis japonica in the Philippines.
Southeast Asian J Trop Med Public Health
;
1976 Jun; 7(2): 306-9
Artigo
em Inglês
| IMSEAR
| ID: sea-34655
ABSTRACT
For the past several decades, the drug being used for the treatment of schistosomiasis in the Philippines has been Stibophen. It is administered intramuscularly at a dose of 1 ml per 10 kg body weight with a maximum of 5 ml every other day after 2 initial daily smaller sensitivity doses at a total dose of 45 to 70 ml fof adult patients. In recent years, a number of drugs for the treatment of schistosomiasis have been developed. These were evaluated clinically either in the hospital or in field trials in Leyte. Unfortunately, none of these were found to be suitable for mass treatment on account of toxicity to prolonged course of treatment. In view of the pressing need for a safe and effective schistosomicidal agent, the search for a better drug is imperative.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Esquistossomose
/
Esquistossomicidas
/
Tartaratos
/
Benzenossulfonatos
/
Humanos
/
Ensaios Clínicos como Assunto
/
Adulto
/
Cisteína
/
Avaliação de Medicamentos
/
Compostos de Anilina
Idioma:
Inglês
Revista:
Southeast Asian J Trop Med Public Health
Ano de publicação:
1976
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS